EGFR and ovarian carcinoma: Autocrine loop with ERBB2 (EGFR family of tyrosine kinase receptors) induced by YAP to bypass EGFR (epidermal growth factor receptor) inactivation regulates ovarian cancer initiation and progression through Hippo kinases inhibition [44].